Investor’s Toolkit: Key Ratios for Assessing Celldex Therapeutics Inc. (CLDX)’s Performance

Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Celldex Therapeutics Inc. (NASDAQ: CLDX) closed the day trading at $39.47 down -1.60% from the previous closing price of $40.11. In other words, the price has decreased by -$1.60 from its previous closing price. On the day, 0.55 million shares were traded. CLDX stock price reached its highest trading level at $41.1 during the session, while it also had its lowest trading level at $39.39.

Ratios:

For a better understanding of CLDX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 31.77 and its Current Ratio is at 31.77. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

On November 10, 2023, Wells Fargo Upgraded its rating to Equal Weight which previously was Underweight but kept the price unchanged to $27.

On August 22, 2023, Wells Fargo started tracking the stock assigning a Underweight rating and target price of $21.Wells Fargo initiated its Underweight rating on August 22, 2023, with a $21 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLDX now has a Market Capitalization of 2643673088 and an Enterprise Value of 1779757312. For the stock, the TTM Price-to-Sale (P/S) ratio is 428.58 while its Price-to-Book (P/B) ratio in mrq is 3.10. Its current Enterprise Value per Revenue stands at 293.109 whereas that against EBITDA is -12.097.

Stock Price History:

Over the past 52 weeks, CLDX has reached a high of $53.18, while it has fallen to a 52-week low of $22.11. The 50-Day Moving Average of the stock is -4.42%, while the 200-Day Moving Average is calculated to be 14.33%.

Shares Statistics:

Over the past 3-months, CLDX traded about 926.61K shares per day on average, while over the past 10 days, CLDX traded about 588170 shares per day. A total of 65.91M shares are outstanding, with a floating share count of 64.29M. Insiders hold about 2.46% of the company’s shares, while institutions hold 103.29% stake in the company. Shares short for CLDX as of 1714435200 were 6989589 with a Short Ratio of 7.54, compared to 1711584000 on 6557945. Therefore, it implies a Short% of Shares Outstanding of 6989589 and a Short% of Float of 12.280000000000001.

Most Popular